About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Baltimore | 178 Studies

Clinical Trials Colorectal CancerBaltimore

Colorectal Cancer Clinical Trials in Baltimore

Find 178 clinical trials for colorectal cancer near Baltimore, Maryland. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 178 trials

TerminatedEverolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous TherapyRATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00390364·Baltimore, Maryland RecruitingCapecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal CancerThe purpose of this study is to evaluate the safety and clinical activity of combining cemiplimab, cemiplimab/fianlimab, or cemiplimab/REGN7075 with capecitabine/oxaliplatin…NCT07281768·Baltimore, Maryland CompletedVaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the LiverRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00033748·Anniston, Alabama and 74 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingDurvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung CancerThis randomized phase II trial studies the side effects of durvalumab and tremelimumab and to see how well they work with or without high or low-dose radiation therapy in treating…NCT02888743·Phoenix, Arizona and 41 others

CompletedA Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)This is a Phase 1/2, open label study. Phase 1 consists of 2 parts.NCT02327078·Birmingham, Alabama and 23 others

CompletedStudy of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)The purpose of this study is to assess the safety and efficacy of lenvatinib (MK-7902/E7080) in combination with pembrolizumab (MK-3475) in participants with metastatic colorectal…NCT04776148·Monterey, California and 94 others

CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionThis phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction.NCT01638533·Duarte, California and 11 others

Active not recruitingPooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerPhase 1 study for patients with resected PDAC after neoadjuvant and/ or adjuvant chemotherapy and/or radiation, as well as patients with metastatic colorectal cancer who have…NCT04117087·Baltimore, Maryland

CompletedPhysical Activities by Technology Help (PATH)PATH is a research study for cancer survivors to help participants to become more active. Studies suggested an association between inactivity and cancer.NCT03212079·Baltimore, Maryland

TerminatedStudy of INCA 0186 in Subjects With Advanced Solid TumorsThis is an open-label, nonrandomized, multicenter, dose escalation, and dose expansion first-in human (FIH) Phase 1 study to determine the safety, tolerability, PK…NCT04989387·Los Angeles, California and 31 others

CompletedMulti-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerThe primary objective is to determine the sensitivity and specificity of the Exact Colorectal Cancer (CRC) screening test for colorectal cancer, using colonoscopy as the reference…NCT01397747·Birmingham, Alabama and 183 others

CompletedAn Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerThe purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancerNCT00207155·Duarte, California and 13 others

CompletedCombination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck CancerThe purpose of the study is to determine the safety, tolerability and maximum tolerated dose of Urelumab in combination with Cetuximab in patients with Advanced/Metastatic…NCT02110082·Stanford, California and 6 others

CompletedA Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersThis is a Phase 1, open-label, 2-part, multi-center study evaluating the safety, tolerability, PK, pharmacodynamics (PD), immunogenicity, and antitumor activity of CUE-102…NCT05360680·Phoenix, Arizona and 14 others

CompletedOxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With SurgeryPURPOSE: This randomized phase III trial is studying giving oxaliplatin, leucovorin calcium, and fluorouracil together to compare how well they work when given together with or…NCT01150045·Mobile, Alabama and 841 others

CompletedA Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.This a Phase III trial designed to determine if IV casopitant plus dexamethasone and ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and…NCT00601172·Hot Springs, Arkansas and 95 others

CompletedIrinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyRATIONALE: Drugs used in chemotherapy, such as irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT01079780·Birmingham, Alabama and 254 others

Active not recruitingCORRECT Study of Minimal Residual Disease Detection in Colorectal CancerThe CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer.NCT05210283·Mission Hills, California and 31 others

SuspendedA Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NPX267 is an antibody drug targeting the inhibitory receptor for B7-H7 (HHLA2) which may control evasion of the immune response in tumors.NCT05958199·Baltimore, Maryland and 6 others

TerminatedStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationA Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.NCT05737706·Phoenix, Arizona and 13 others

PreviousPage 6 of 9Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma